In-vitro susceptibility of Klebsiella oxytoca strains to 13 β-lactams in the presence and absence of β-lactamase inhibitors

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 5, 1996, Pages 931-942

  Fournier, Bénédicte ^a,b   Lagrange, Philippe H ^a   Philippon, Alain ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFALOTIN; CEFAMANDOLE; CEFOPERAZONE; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; IMIPENEM; LATAMOXEF; PENICILLIN DERIVATIVE; PIPERACILLIN; SULBACTAM; TAZOBACTAM; TICARCILLIN;

AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; DILUTION; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; MULTIVARIATE ANALYSIS; NONHUMAN; PENICILLIN RESISTANCE; STATISTICAL ANALYSIS;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ENZYME INHIBITORS; ESCHERICHIA COLI; GENE TRANSFER TECHNIQUES; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS;

EID: 0029896103     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.5.931     Document Type: Article

References (30)

1. Arakawa, Y., Ohta, M., Kido, N., Mori, M., Ito, H., Komatsu et al. (1989). Chromosomal β-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 33, 63-70.
2. Arlet, G. & Philippon, A. (1991). Construction by polymerase chain reaction and intragenic DNA probes for the three main types of transferable β-lactamases (TEM, SHV, CARB). FEMS Microbiology Letters 82, 19-26.
3. Barthélémy, M., Péduzzi, J., Bernard, H., Tancrède, C. & Labia, R. (1992). Close amino-acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochimica et Biophysica Acta 1122, 15-22.
4. Buirma, R. J. A., Horrevorts, A. M. & Wagenvoort, J. H. T. (1991). Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. Scandinavian Journal of Infectious Diseases, Suppl. 78, 35-44.
5. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
6. Chardon, H., Pachetti, C., Collet, L., Bellon, O. & Lagier, E. (1993). Détermination du point isoélectrique des β-lactamases extraites de 67 souches de Klebsiella oxytoca et comportement phénotypique vis-à-vis de huit β-lactamines. Pathologie Biologie 41, 343-8.
7. Comité de l'antibiogramme de la Société Française de Microbiologie. (1994). Communiqué 1994. Pathologie Biologie 42, i-viii.
8. Fournier, B., Arlet, G., Lagrange, P. H. & Philippon, A. (1994). Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded β-lactamase. FEMS Microbiology Letters 116, 31-6.
9. Fournier, B., Lu, C. Y., Lagrange, P. H., Krishnamoorthy, R. & Philippon, A. (1995). Point mutation in the Pribnow box, the molecular basis of β-lactamase overproduction in Klebsiella oxytoca. Antimicrobial Agents and Chemotherapy 39, 1365-8.
10. Gutmann, L., Kitzis, M. D., Yamabe, S. & Acar, J. F. (1986). Comparative evaluation of a new β-lactamase inhibitor, YTR 830, combined with different β-lactam antibiotics against bacteria harbouring known β-lactamases. Antimicrobial Agents and Chemotherapy 29, 955-7.
11. Hart, C. A. & Percival, A. (1982). Resistance to cephalosporins among gentamicin-resistant klebsiellae. Journal of Antimicrobial Chemotherapy 9, 275-86.
12. Inoue, M., Maejima, T., Sanai, S., Okamoto, R. & Hashimoto, H. (1991). Purification and properties of a chromosomal β-lactamase from Klebsiella oxytoca. Journal of Antibiotics 44, 435-40.
13. Kado, C. I. & Liu, S. T. (1981). Rapid procedure for detection and isolation of large and small plasmids. Journal of Bacteriology 145, 1365-73.
14. Korvick, J. A., Bryan, C. S., Farber, B., Beam, T. R., Schenfeld, L., Muder, R. R. et al. (1992). Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotics combinations versus monotherapy. Antimicrobial Agents and Chemotherapy 36, 2639-44.
15. Labia, R. & Barthélémy, M. (1979). L'enzymogramme des β-lactamases: adaptation en gel de la méthode iodométrique. Annales de Microbiologie (Institut Pasteur) 130B, 295-304.
16. Labia, R., Morand, A., Guionie, M., Heitz, M. & Pitton, J. S. (1986). β-Lactamases de Klebsiella oxytoca: étude de leur action sur les céphalosporines de troisième génération. Pathologie Biologie 34, 611-5.
17. Legrand, P., Fournier, G., Buré, A., Jarlier, V., Nicolas, M. H., Decré, D. et al. (1989). Detection of extended broad-spectrum ́-lactamases in Enterobacteriaceae in four French hospitals. European Journal of Clinical Microbiology and Infectious Diseases 8, 527-9.
18. Montgomerie, J. Z. (1979). Epidemiology of Klebsiella and hospital-associated infections. Reviews of Infectious Diseases 1, 736-53.
19. Muratami, T., Yokota, E., Nakane T., Inoue, E. & Mitsuhashi, S. (1993). In-vitro evaluation of the four β-lactamases inhibitors: BRL42715, clavulanic acid, sulbactam and tazobactam. Journal of Antimicrobial Chemotherapy 32, 421-9.
20. Philippon, A., Labia, R. & Jacoby, G. (1989). Extended-spectrum β-lactamases. Antimicrobial Agents Chemotherapy 33, 1131-6.
21. Sanders, C. C. & Sanders, W. E. (1983). Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Reviews of Infectious Diseases 5, 639-48.
22. Shah, P. M., Asanger, R. & Kahan, F. M. (1991). Incidence of multi-resistance in gram-negative aerobes from intensive care units of 10 German hospitals. Scandinavian Journal of Infectious Diseases, Suppl. 78, 22-34.
23. Shah, P. M. & Stille, W. (1983). Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third-generation cephalosporins. Journal of Antimicrobial Chemotherapy 11, 597-8.
24. Shannon, K. P., King, A., Phillips, I., Nicolas, M. H. & Philippon, A. (1990). Importance of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom. Journal of Antimicrobial Chemotherapy 25, 342-51.
25. Sirot, D. L., Goldstein, F. W., Soussy, C. J., Courtieu, A. L., Husson, M. O., Lemozy, J. et al. (1992). Resistance to cefotaxime and seven other β-lactams in members of family Enterobacteriaceae: a 3-year survey in France. Antimicrobial Agents and Chemotherapy 36, 1677-81.
26. Snydman, D. R. (1991). Clinical implications of multi-drug resistance in the intensive care unit. Scandinavian Journal of Infectious Diseases, Suppl. 78, 54-63.
27. Sykes, R. B. & Matthew, M. (1976). The β-lactamases of Gram-negative bacteria and their role in resistance to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 2, 115-57.
28. Then, R. L., Glauser, M. P., Angehrn, P. & Arisawa, M. (1983). Cephalosporin resistance in strains of Klebsiella oxytoca isolated during antibiotic therapy. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene 254, 469-79.
29. Vedel, G., Belaaouaj, A., Gilly, L., Labia, R., Philippon, A., Nevot, P. et al. (1992). Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamases inhibitors. Journal of Antimicrobial Chemotherapy 30, 449-62.
30. Wu, S. W., Dornbusch, K., Norgren, M. & Kronvall, G. (1992). Extended spectrum β-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. Journal of Antimicrobial Chemotherapy 30, 3-16.